239 related articles for article (PubMed ID: 12806595)
1. Effect of angiotensin-converting enzyme inhibition on endothelial function and insulin sensitivity in hypertensive patients.
Tezcan H; Yavuz D; Toprak A; Akpinar I; Koç M; Deyneli O; Akalin S
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):119-23. PubMed ID: 12806595
[TBL] [Abstract][Full Text] [Related]
2. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
[TBL] [Abstract][Full Text] [Related]
3. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.
Buus NH; Jørgensen CG; Mulvany MJ; Sørensen KE
Blood Press; 2007; 16(2):106-13. PubMed ID: 17612909
[TBL] [Abstract][Full Text] [Related]
4. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
[TBL] [Abstract][Full Text] [Related]
5. [Angiotensin converting enzyme inhibitors increase insulin sensitivity in offspring of families with hypertension even after active interventions. Results of a clamp study].
Vlasáková Z; Válek J
Cas Lek Cesk; 1997 Nov; 136(22):693-7. PubMed ID: 9476381
[TBL] [Abstract][Full Text] [Related]
6. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension.
Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Horio T; Yoshimasa Y; Harano Y
Am J Hypertens; 2004 Mar; 17(3):228-32. PubMed ID: 15001196
[TBL] [Abstract][Full Text] [Related]
7. Some metabolic aspects of essential hypertension and its treatment.
Santoro D; Galvan AQ; Natali A; Ferrannini E
Am J Med; 1993 Apr; 94(4A):32S-39S. PubMed ID: 8488854
[TBL] [Abstract][Full Text] [Related]
8. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal blood pressure but not insulin resistance influences endothelial function in treated hypertensive patients.
Konrad T; Franke S; Schneider F; Bär F; Vetter G; Winkler K
J Hum Hypertens; 2011 Jan; 25(1):18-24. PubMed ID: 20237501
[TBL] [Abstract][Full Text] [Related]
10. Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration.
Joannides R; Bellien J; Thurlure C; Iacob M; Abeel M; Thuillez C
Am J Hypertens; 2008 Jun; 21(6):679-84. PubMed ID: 18443573
[TBL] [Abstract][Full Text] [Related]
11. Olmesartan improves endothelial function in hypertensive patients: link with extracellular superoxide dismutase.
Takiguchi S; Ayaori M; Uto-Kondo H; Iizuka M; Sasaki M; Komatsu T; Takase B; Adachi T; Ohsuzu F; Ikewaki K
Hypertens Res; 2011 Jun; 34(6):686-92. PubMed ID: 21307868
[TBL] [Abstract][Full Text] [Related]
12. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
[TBL] [Abstract][Full Text] [Related]
13. Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes.
Cheetham C; O'Driscoll G; Stanton K; Taylor R; Green D
Clin Sci (Lond); 2001 Jan; 100(1):13-7. PubMed ID: 11115412
[TBL] [Abstract][Full Text] [Related]
14. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M
Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851
[TBL] [Abstract][Full Text] [Related]
15. The effect of the year angiotensin-converting enzyme inhibitors (ACE I) intake on circadian heart rate variability in patients with primary hypertension.
Banach T; Kolasińska-Kloch W; Furgała A; Laskiewicz J
Folia Med Cracov; 2001; 42(3):129-40. PubMed ID: 12353420
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydrobiopterin increases insulin sensitivity in patients with type 2 diabetes and coronary heart disease.
Nyström T; Nygren A; Sjöholm A
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E919-25. PubMed ID: 15265759
[TBL] [Abstract][Full Text] [Related]
17. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance.
Xiang GD; Sun HL; Zhao LS; Hou J; Yue L; Xu L
Clin Endocrinol (Oxf); 2008 May; 68(5):716-23. PubMed ID: 18070144
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors reveal non-NO-, non-prostacycline-mediated endothelium-dependent relaxation in internal thoracic artery of hypertensive patients.
Deja MA; Gołba KS; Widenka K; Mrozek R; Biernat J; Kolowca M; Malinowski M; Woś S
Int J Cardiol; 2005 Jul; 102(3):455-60. PubMed ID: 16004891
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
